Tolerability of β-blockers in outpatients with refractory heart failure who were receiving continuous milrinone

Pharmacotherapy

Volumn 27, Issue 5, 2007, Pages 697-706

  Earl, Grace L ^a   Verbos Kazanas, Marybeth A ^b   Fitzpatrick, Jane M ^b,c   Narula, Jagat ^b,c  

^a UNIVERSITY OF THE SCIENCES   (United States)

^b HAHNEMANN UNIVERSITY HOSPITAL   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

blockers; Carvedilol; Congestive heart failure; Metoprolol tartrate; Milrinone; Positive inotrope; Pretransplant management; Refractory heart failure

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; CREATININE; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; HYDRALAZINE; METOPROLOL TARTRATE; MILRINONE; NITRATE; SODIUM; VASODILATOR AGENT; WARFARIN;

ADULT; BLOOD PRESSURE; CARDIOMYOPATHY; CONFIDENCE INTERVAL; CONTINUOUS INFUSION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE; HUMAN; INDUCED HYPOTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; REVIEW; SIDE EFFECT; SODIUM BLOOD LEVEL; UNSPECIFIED SIDE EFFECT; VENOUS THROMBOEMBOLISM;

ADRENERGIC BETA-ANTAGONISTS; AGED; ARRHYTHMIA; BLOOD PRESSURE; CARBAZOLES; CARDIAC OUTPUT, LOW; CARDIOTONIC AGENTS; CREATININE; DIURETICS; DRUG THERAPY, COMBINATION; FEMALE; HEART RATE; HOSPITALS, UNIVERSITY; HUMANS; HYPOTENSION; MALE; METOPROLOL; MIDDLE AGED; MILRINONE; OXYGEN CONSUMPTION; PROPANOLAMINES; RETROSPECTIVE STUDIES; SODIUM; VASODILATOR AGENTS;

EID: 34247849244     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.27.5.697     Document Type: Review

References (13)

1. Thom T, Haase N, Rosamond W, et al. Heart disease and stroke statistics-2006 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation 2006;113:e85-151.
2. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). Circulation 2005;112:154-235. Available from http://circ.ahajournals.org/cgi/reprint/112/12/ e154. Accessed April 15, 2006.
3. Adams KF, Lindenfeld J, Arnold JMO, et al, for the Heart Failure Society of America. HFSA 2006 comprehensive heart failure practice guideline. J Card Fail 2006;12:e1-122.
4. Cuffe MS, Califf RM, Adams KF, et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 2002;287:1541-57.
5. Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term ventricular assist device for end-stage heart failure. N Engl J Med 2001;345(20):1435-43.
6. Packer M, Coats AJ, Fowler MB, et al. Effect of carvedilol on survival in severe chronic heart failure (COPERNICUS). N Engl J Med 2001;344(22):1651-8.
7. Goldstein S, Fagerberg B, Hjalmarson A, et al. Metoprolol controlled release/extended release in patients with severe heart failure. J Am Coll Cardiol 2001;38(4):932-8.
8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16(1):31-41.
9. Shakar SF, Abraham WT, Gilbert EM, et al. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure. J Am Coll Cardiol 1998;31(6): 1336-40.
10. Kumar A, Choudhary G, Antonio C, et al. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy. Am Heart J 2001;142(3):512-15.
11. GlaxoSmithKline. Coreg (carvedilol) tablets package insert. Research Triangle Park, NC; 2005. Available from www.coreg.com. Accessed July 13, 2006.
12. Aranda JM Jr, Schofield RS, Pauly DF, et al. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial. Am Heart J 2003;145(2):324-9.
13. Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342(8885):1441-6.